Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:35463077

In the Tumor Microenvironment, ETS1 Is an Oncogenic Immune Protein: An Integrative Pancancer Analysis.

Zixuan Wu · Yanhui Jiang · Xuyan Huang · Minjie Cai · Kai Yuan · Peidong Huang · Zuhong Wang

Evidence-based complementary and alternative medicine : eCAM · 2022 doi:10.1155/2022/7730433

Paper

complete

Experiment

complete

Data

partial

Analysis

complete

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:35463077
kind
science-record
content_hash
sha256:b2f29ee37bf618dfb54961a00bb70bbecdb8a49c64340c9c85372cbde19a9169
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T18:14:19Z
updated_at
2026-11-01T22:48:54Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
In the Tumor Microenvironment, ETS1 Is an Oncogenic Immune Protein: An Integrative Pancancer Analysis.
doi
10.1155/2022/7730433
pmid
35463077
authors array · 7 items
[0]
Zixuan Wu
[1]
Yanhui Jiang
[2]
Xuyan Huang
[3]
Minjie Cai
[4]
Kai Yuan
[5]
Peidong Huang
[6]
Zuhong Wang
journal
Evidence-based complementary and alternative medicine : eCAM
year
2022
abstract
Background: Previous research suggested that ETS1 (ETS proto-oncogene 1, transcription factor) could be useful for cancer immunotherapy. The processes underlying its therapeutic potential, on the other hand, have yet to be thoroughly investigated. The purpose of this study was to look into the relationship between ETS1 expression and immunity. Methods: TCGA and GEO provide raw data on 33 different cancers as well as GSE67501, GSE78220, and IMvigor210. In addition, we looked at ETS1's genetic changes, expression patterns, and survival studies. The linkages between ETS1 and TME, as well as its association with immunological processes/elements and the major histocompatibility complex, were explored to effectively understand the role of ETS1 in cancer immunotherapy. Three distinct immunotherapeutic cohorts were employed to examine the relationship between ETS1 and immunotherapeutic response. Results: ETS1 expression was shown to be high in tumor tissue. ETS1 overexpression is linked to a worse clinical outcome in individuals with overall survival. Immune cell infiltration, immunological modulators, and immunotherapeutic signs are all linked to ETS1. Overexpression of ETS1 is linked to immune-related pathways. However, no statistically significant link was found between ETS1 and immunotherapeutic response. Conclusions: ETS1 may be a reliable biomarker for tumor prognosis and a viable prospective therapeutic target for human cancer immunotherapy (e.g., KIRP, MESO, BLCA, KIRC, and THYM).
claims array · 2 items
[0] object · 6 fields
id
claim-method
statement
We employed the log-rank and univariate Cox proportional hazards models. Clinical factors such as age, gender, grade, and stage were considered for multivariate Cox regression.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:35463077
locator
sections[13] "5.2. The Relationship between ETS1 and Survival and Clinical Stage" paragraph 2
quote
We employed the log-rank and univariate Cox proportional hazards models. Clinical factors such as age, gender, grade, and stage were considered for multivariate Cox regression.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
Patients who gave informed consent to use their data have been uploaded to publicly accessible TCGA databases. At their leisure, users can get and publish relevant articles depending on the needed data. The (diseases) data used to support the findings of this study have been deposited into the (TCGA) repository (https://portal.gdc.cancer.gov/).
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:35463077
locator
sections[19] "Data Availability" paragraph 2
quote
Patients who gave informed consent to use their data have been uploaded to publicly accessible TCGA databases. At their leisure, users can get and publish relevant articles depending on the needed data. The (diseases) data used to support the findings of this study have been deposited into the (TCGA) repository (https://portal.gdc.cancer.gov/).
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:35463077
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE67501
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE67501
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 3 items
[0] object · 15 fields
id
source:pmid:35463077
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1155/2022/7730433
sha256
sha256:244d14ef8721dde075f9ca489a7d75b0ef2b433962072ec31dd8dc292b6f8e34
bytes
24931
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1155/2022/7730433
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC9033344
source
europe_pmc_fulltext
coverage
whole_body_without_references
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:GSE67501
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE67501
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE67501
version
null
note
Patients who gave informed consent to use their data have been uploaded to publicly accessible TCGA databases. At their leisure, users can get and publish relevant articles depending on the needed data. The (diseases) data used to support the findings of this study have been deposited into the (TCGA) repository (https://portal.gdc.cancer.gov/).
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
Patients who gave informed consent to use their data have been uploaded to publicly accessible TCGA databases. At their leisure, users can get and publish relevant articles depending on the needed data. The (diseases) data used to support the findings of this study have been deposited into the (TCGA) repository (https://portal.gdc.cancer.gov/).
access_statement_kind
data_availability_statement
sample_accessions array · 11 items
[0]
GSM1648114
[1]
GSM1648115
[2]
GSM1648116
[3]
GSM1648117
[4]
GSM1648118
[5]
GSM1648119
[6]
GSM1648120
[7]
GSM1648121
[8]
GSM1648122
[9]
GSM1648123
[10]
GSM1648124
sample_count
11
group_sizes
null
group_sizes_basis
null
platform
14951
taxon
Homo sapiens
title
Expression data in human renal cell carcinoma samples from patients who did or did not respond to anti-PD-1 (Nivolumab) immunotherapy
resolution_checked_at
2026-11-01T17:30:42Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 15 fields
id
data:geo:GSE78220
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE78220
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE78220
version
null
note
Patients who gave informed consent to use their data have been uploaded to publicly accessible TCGA databases. At their leisure, users can get and publish relevant articles depending on the needed data. The (diseases) data used to support the findings of this study have been deposited into the (TCGA) repository (https://portal.gdc.cancer.gov/).
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
Patients who gave informed consent to use their data have been uploaded to publicly accessible TCGA databases. At their leisure, users can get and publish relevant articles depending on the needed data. The (diseases) data used to support the findings of this study have been deposited into the (TCGA) repository (https://portal.gdc.cancer.gov/).
access_statement_kind
data_availability_statement
sample_accessions array · 28 items
[0]
GSM2069823
[1]
GSM2069824
[2]
GSM2069825
[3]
GSM2069826
[4]
GSM2069827
[5]
GSM2069828
[6]
GSM2069829
[7]
GSM2069830
[8]
GSM2069831
[9]
GSM2069832
[10]
GSM2069833
[11]
GSM2069834
[12]
GSM2069835
[13]
GSM2069836
[14]
GSM2069837
[15]
GSM2069838
[16]
GSM2069839
[17]
GSM2069840
[18]
GSM2069841
[19]
GSM2069842
[20]
GSM2069843
[21]
GSM2069844
[22]
GSM2069845
[23]
GSM2069846
[24]
GSM2069847
[25]
GSM2069848
[26]
GSM2069849
[27]
GSM2069850
sample_count
28
group_sizes
null
group_sizes_basis
null
platform
11154
taxon
Homo sapiens
title
mRNA expressions in pre-treatment melanomas undergoing anti-PD-1 checkpoint inhibition therapy
resolution_checked_at
2026-11-01T15:39:55Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
gaps array · 4 items
[0]
asset:data:geo:GSE67501 not downloaded
[1]
asset:data:geo:GSE67501 licence not read
[2]
asset:data:geo:GSE78220 not downloaded
[3]
asset:data:geo:GSE78220 licence not read
analysis object · 4 fields
state
complete
methods array · 2 items
[0] object · 10 fields
id
method-1
family
survival_analysis
specific
cox_proportional_hazards
label
Survival analysis
dsl_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
1
band
verbatim
quote
We employed the log-rank and univariate Cox proportional hazards models. Clinical factors such as age, gender, grade, and stage were considered for multivariate Cox regression.
[1] object · 10 fields
id
method-2
family
survival_analysis
specific
log_rank_test
label
Survival analysis
dsl_operations array · 1 item
[0]
logrank_test
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.8
band
high
quote
log-rank
targets array · 0 items
gaps array · 0 items
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 2 items
[0]
GSE67501
[1]
GSE78220
resolved_accessions array · 2 items
[0]
GSE67501
[1]
GSE78220
statements array · 1 item
[0]
Patients who gave informed consent to use their data have been uploaded to publicly accessible TCGA databases. At their leisure, users can get and publish relevant articles depending on the needed data. The (diseases) data used to support the findings of this study have been deposited into the (TCGA) repository (https://portal.gdc.cancer.gov/).
basis
The paper names GSE67501, GSE78220 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 1 item
[0]
cox_ph
assets array · 2 items
[0]
source:pmid:35463077
[1]
data:geo:GSE67501
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:GSE67501
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-11-01T17:43:18Z
independence
single_reader
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
5
usage object · 3 fields
prompt_tokens
7766
completion_tokens
2179
cached_tokens
264
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:35463077
type
paper
label
pmid:35463077
[1] object · 3 fields
id
source:pmid:35463077
type
manuscript
label
PMID 35463077 full text
[2] object · 3 fields
id
data:geo:GSE67501
type
dataset
label
GEO GSE67501
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:35463077
type
paper
label
pmid:35463077
[1] object · 3 fields
id
source:pmid:35463077
type
manuscript
label
PMID 35463077 full text
[2] object · 3 fields
id
data:geo:GSE67501
type
dataset
label
GEO GSE67501
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-35463077
type
extraction
used array · 1 item
[0]
source:pmid:35463077
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-GSE67501
type
accession_resolution
used array · 1 item
[0]
data:geo:GSE67501
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:35463077
parent_hash
sha256:d3a993c9b626d5133bf08cbfb863609598cb23fa98512fcb3ab6d0cc05eb61a4
fork_of
null
gaps array · 8 items
[0]
asset:data:geo:GSE67501 licence not read
[1]
asset:data:geo:GSE67501 not downloaded
[2]
asset:data:geo:GSE78220 licence not read
[3]
asset:data:geo:GSE78220 not downloaded
[4]
execution.not_run
[5]
review.human_critique
[6]
review.independent_reader
[7]
review.machine_critique
assays array · 1 item
[0] object · 11 fields
role
analysis
definition_id
survival_analysis
definition_version
f2132e96ae6c7a4e
required_operations array · 1 item
[0]
cox_ph
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
We employed the log-rank and univariate Cox proportional hazards models. Clinical factors such as age, gender, grade, and stage were considered for multivariate Cox regression.
order_basis
analysis_only
id
assay:1
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:35463077", "kind": "science-record", "revision": 4, "content_hash": "sha256:b2f29ee37bf618dfb54961a00bb70bbecdb8a49c64340c9c85372cbde19a9169", "created_at": "2026-11-01T18:14:19Z", "updated_at": "2026-11-01T22:48:54Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "In the Tumor Microenvironment, ETS1 Is an Oncogenic Immune Protein: An Integrative Pancancer Analysis.", "doi": "10.1155/2022/7730433", "pmid": "35463077", "authors": ["Zixuan Wu", "Yanhui Jiang", "Xuyan Huang", "Minjie Cai", "Kai Yuan", "Peidong Huang", "Zuhong Wang"], "journal": "Evidence-based complementary and alternative medicine : eCAM", "year": 2022, "abstract": "Background: Previous research suggested that ETS1 (ETS proto-oncogene 1, transcription factor) could be useful for cancer immunotherapy. The processes underlying its therapeutic potential, on the other hand, have yet to be thoroughly investigated. The purpose of this study was to look into the relationship between ETS1 expression and immunity.\nMethods: TCGA and GEO provide raw data on 33 different cancers as well as GSE67501, GSE78220, and IMvigor210. In addition, we looked at ETS1's genetic changes, expression patterns, and survival studies. The linkages between ETS1 and TME, as well as its association with immunological processes/elements and the major histocompatibility complex, were explored to effectively understand the role of ETS1 in cancer immunotherapy. Three distinct immunotherapeutic cohorts were employed to examine the relationship between ETS1 and immunotherapeutic response.\nResults: ETS1 expression was shown to be high in tumor tissue. ETS1 overexpression is linked to a worse clinical outcome in individuals with overall survival. Immune cell infiltration, immunological modulators, and immunotherapeutic signs are all linked to ETS1. Overexpression of ETS1 is linked to immune-related pathways. However, no statistically significant link was found between ETS1 and immunotherapeutic response.\nConclusions: ETS1 may be a reliable biomarker for tumor prognosis and a viable prospective therapeutic target for human cancer immunotherapy (e.g., KIRP, MESO, BLCA, KIRC, and THYM).", "claims": [{"id": "claim-method", "statement": "We employed the log-rank and univariate Cox proportional hazards models. Clinical factors such as age, gender, grade, and stage were considered for multivariate Cox regression.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:35463077", "locator": "sections[13] \"5.2. The Relationship between ETS1 and Survival and Clinical Stage\" paragraph 2", "quote": "We employed the log-rank and univariate Cox proportional hazards models. Clinical factors such as age, gender, grade, and stage were considered for multivariate Cox regression."}], "state": "complete"}, {"id": "claim-data-access", "statement": "Patients who gave informed consent to use their data have been uploaded to publicly accessible TCGA databases. At their leisure, users can get and publish relevant articles depending on the needed data. The (diseases) data used to support the findings of this study have been deposited into the (TCGA) repository (https://portal.gdc.cancer.gov/).", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:35463077", "locator": "sections[19] \"Data Availability\" paragraph 2", "quote": "Patients who gave informed consent to use their data have been uploaded to publicly accessible TCGA databases. At their leisure, users can get and publish relevant articles depending on the needed data. The (diseases) data used to support the findings of this study have been deposited into the (TCGA) repository (https://portal.gdc.cancer.gov/)."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": "", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:35463077"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE67501"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE67501"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:35463077", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1155/2022/7730433", "sha256": "sha256:244d14ef8721dde075f9ca489a7d75b0ef2b433962072ec31dd8dc292b6f8e34", "bytes": 24931, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1155/2022/7730433", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC9033344", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE67501", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE67501", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE67501", "version": null, "note": "Patients who gave informed consent to use their data have been uploaded to publicly accessible TCGA databases. At their leisure, users can get and publish relevant articles depending on the needed data. The (diseases) data used to support the findings of this study have been deposited into the (TCGA) repository (https://portal.gdc.cancer.gov/).", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "Patients who gave informed consent to use their data have been uploaded to publicly accessible TCGA databases. At their leisure, users can get and publish relevant articles depending on the needed data. The (diseases) data used to support the findings of this study have been deposited into the (TCGA) repository (https://portal.gdc.cancer.gov/).", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM1648114", "GSM1648115", "GSM1648116", "GSM1648117", "GSM1648118", "GSM1648119", "GSM1648120", "GSM1648121", "GSM1648122", "GSM1648123", "GSM1648124"], "sample_count": 11, "group_sizes": null, "group_sizes_basis": null, "platform": "14951", "taxon": "Homo sapiens", "title": "Expression data in human renal cell carcinoma samples from patients who did or did not respond to anti-PD-1 (Nivolumab) immunotherapy", "resolution_checked_at": "2026-11-01T17:30:42Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "data:geo:GSE78220", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE78220", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE78220", "version": null, "note": "Patients who gave informed consent to use their data have been uploaded to publicly accessible TCGA databases. At their leisure, users can get and publish relevant articles depending on the needed data. The (diseases) data used to support the findings of this study have been deposited into the (TCGA) repository (https://portal.gdc.cancer.gov/).", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "Patients who gave informed consent to use their data have been uploaded to publicly accessible TCGA databases. At their leisure, users can get and publish relevant articles depending on the needed data. The (diseases) data used to support the findings of this study have been deposited into the (TCGA) repository (https://portal.gdc.cancer.gov/).", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM2069823", "GSM2069824", "GSM2069825", "GSM2069826", "GSM2069827", "GSM2069828", "GSM2069829", "GSM2069830", "GSM2069831", "GSM2069832", "GSM2069833", "GSM2069834", "GSM2069835", "GSM2069836", "GSM2069837", "GSM2069838", "GSM2069839", "GSM2069840", "GSM2069841", "GSM2069842", "GSM2069843", "GSM2069844", "GSM2069845", "GSM2069846", "GSM2069847", "GSM2069848", "GSM2069849", "GSM2069850"], "sample_count": 28, "group_sizes": null, "group_sizes_basis": null, "platform": "11154", "taxon": "Homo sapiens", "title": "mRNA expressions in pre-treatment melanomas undergoing anti-PD-1 checkpoint inhibition therapy", "resolution_checked_at": "2026-11-01T15:39:55Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}], "gaps": ["asset:data:geo:GSE67501 not downloaded", "asset:data:geo:GSE67501 licence not read", "asset:data:geo:GSE78220 not downloaded", "asset:data:geo:GSE78220 licence not read"]}, "analysis": {"state": "complete", "methods": [{"id": "method-1", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "We employed the log-rank and univariate Cox proportional hazards models. Clinical factors such as age, gender, grade, and stage were considered for multivariate Cox regression."}}, {"id": "method-2", "family": "survival_analysis", "specific": "log_rank_test", "label": "Survival analysis", "dsl_operations": ["logrank_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "log-rank"}}], "targets": [], "gaps": []}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["cox_ph"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE67501", "GSE78220"], "resolved_accessions": ["GSE67501", "GSE78220"], "statements": ["Patients who gave informed consent to use their data have been uploaded to publicly accessible TCGA databases. At their leisure, users can get and publish relevant articles depending on the needed data. The (diseases) data used to support the findings of this study have been deposited into the (TCGA) repository (https://portal.gdc.cancer.gov/)."], "basis": "The paper names GSE67501, GSE78220 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["cox_ph"], "assets": ["source:pmid:35463077", "data:geo:GSE67501"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE67501"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T17:43:18Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 5, "usage": {"prompt_tokens": 7766, "completion_tokens": 2179, "cached_tokens": 264}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:35463077", "type": "paper", "label": "pmid:35463077"}, {"id": "source:pmid:35463077", "type": "manuscript", "label": "PMID 35463077 full text"}, {"id": "data:geo:GSE67501", "type": "dataset", "label": "GEO GSE67501"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:35463077", "type": "paper", "label": "pmid:35463077"}, {"id": "source:pmid:35463077", "type": "manuscript", "label": "PMID 35463077 full text"}, {"id": "data:geo:GSE67501", "type": "dataset", "label": "GEO GSE67501"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-35463077", "type": "extraction", "used": ["source:pmid:35463077"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE67501", "type": "accession_resolution", "used": ["data:geo:GSE67501"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:35463077", "parent_hash": "sha256:d3a993c9b626d5133bf08cbfb863609598cb23fa98512fcb3ab6d0cc05eb61a4", "fork_of": null, "generation": 3}, "gaps": ["asset:data:geo:GSE67501 licence not read", "asset:data:geo:GSE67501 not downloaded", "asset:data:geo:GSE78220 licence not read", "asset:data:geo:GSE78220 not downloaded", "execution.not_run", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "analysis", "definition_id": "survival_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["cox_ph"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["We employed the log-rank and univariate Cox proportional hazards models. Clinical factors such as age, gender, grade, and stage were considered for multivariate Cox regression."], "order_basis": "analysis_only", "id": "assay:1"}]}